OmniAb Presents New Scientific Data on its OmnidAb™ P

Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibody industry thought leaders and research scientists from around the worldEMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (Nasdaq: OABI) announces the presentation of new scientific data on...

Related Keywords

United States , Emeryville , California , San Diego , Neha Singh , Diego Marina , Matt Foehr , Bob Chen , Christine Vuong , Company Biological Intelligence , Antibody Society , Omniab Inc , Nasdaq , Company Omnichicken , Therapeutics Conference , Senior Scientist , Robust Immune Repertoires , High Affinity Binding , Chief Executive Officer , Bill Harriman , Senior Vice President , Antibody Discovery , Marriott Marquis San Diego , Diverse Omniab Antibody Repertoires , Senior Director , Discovery Systems , Private Securities Litigation Reform Act ,